检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]江西医学院二附院
出 处:《江西医药》1999年第3期134-136,共3页Jiangxi Medical Journal
摘 要:目的讨论中晚期肝癌肝动脉变异及其在中晚期肝癌介入导管治疗中的临床意义。方法对556例中晚期肝癌进行肝动脉介入灌注化疗(TranratheterarterialinfusionTAI)和/或其与化疗栓塞(TranscatheterarterialchemoembolizationTACE)联合治疗,治疗前进行肝动脉造影。结果发现肝动脉变异85例,占153%。我们发现肝动脉无变异者生存期长于有变异者。结论应仔细造影观察有无肝动脉变异,尽可能做到插管高选择性。否则,应另寻其他办法或辅以其他治疗来提高疗效。Objective The correlation between theraputic effect of interventional treatment and aberrant hepatic arteries are analyzed. Methods After hepatic artery radiograply. 556 patients with moderate and advanced hepatocarcimoma were treated by transarterial infusion (TAI) and/ or transarterial chemoembolization (TACE). Results 85 individuals with aberrant hepatic arteries were observed. The survival period of the group without variation of hepatic artery was longer than that of the group with variation. Conclusions Arterioradiography should be performed carefully, Once variant arteries were found, optimal selective catheteriation should be performed as pessible. Otherwise, other therapeutic measures should be considered in order to improve curative effect.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229